# Dementia
 
Dementia

Background

-   Alzheimer’s Disease (AD): short-term memory deficits prominent
-   Frontotemporal Dementia: behavioral (aggressive or disinhibited),
    language (primary progressive aphasias) or memory (Alzheimer’s/FTD
    overlap) variants
-   Lewy Body Dementia: hallucinations, memory difficulties with
    atypical Parkinsonism early
-   Posterior Cortical Atrophy: visual difficulties and ocular apraxia
    preceding memory problems
-   Creutzfeldt-Jakob Disease (CJD): manifests with subacute cognitive
    decline, seizures, vision loss, personality changes. Can develop
    startle myoclonus
-   Corticobasal degeneration: focal neurologic changes with
    parkinsonism
-   Neurosyphilis: rare, but treatable, present with a range of
    cognitive changes. Develop meningovascular encephalitis. Pts can
    develop an arteritis, headache and hydrocephalus.
-   Normal Pressure Hydrocephalus (NPH): “wet, wacky and wobbly” meaning
    incontinence, gait apraxia and cognitive changes (usually frontal
    symptoms)
-   Autoimmune Dementias: includes limbic encephalitis (like NMDA) where
    there are memory and personality changes, autonomic changes,
    hallucinations and seizures

| 0                                                                                                                                                                                                | 1                                                                                                                                                                                                                                              | 2                                                                                                                                                                                                                                                                                                                                                                                                               |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Normal Aging                                                                                                                                                                                     | Mild Cognitive Impairment                                                                                                                                                                                                                      | Alzheimer’s Dementia (DSM IV Diagnostic Crit.)                                                                                                                                                                                                                                                                                                                                                                  |
| \- Mild decline in memory - More effort/time needed to recall new info - New learning slowed but well compensated by lists, calendars, etc. + - No impairment in social & occupation functioning | \- Subjective complaint of cognitive decline in at least one domain (Memory, executive function, language, or visuospatial perception) + - Cognitive decline is noticeable and measurable + - No impairment in social & occupation functioning | \- Memory impairment + - Aphasia (language disturbance) OR - Apraxia (impaired motor ability despite normal motor function) OR - Agnosia (failure to recognize or identify objects despite intact sensory function OR - Disturbed executive functioning + - Causes significant impairment in social & occupation functioning + - Other medical & psychiatric conditions, including delirium, have been excluded |

| 0                            | 1                              | 2                                         | 3                                            | 4                                                                               |
|------------------------------|--------------------------------|-------------------------------------------|----------------------------------------------|---------------------------------------------------------------------------------|
| NaN                          | Alzheimer’s Disease            | Vascular Dementia                         | Lewy Body Dementia                           | Frontotemporal Dementia                                                         |
| Onset                        | Gradual                        | Sudden or stepwise                        | Gradual                                      | Gradual (age \< 60)                                                             |
| Cognitive Domains & Symptoms | Memory, language, visuospatial | Depends on location of ischemia           | Memory, visuospatial                         | Executive dysfunction, personality changes, disinhibition, language, +/- memory |
| Motor Symptoms               | Rare early Apraxia later       | Correlates with ischemia                  | Parkinsonism                                 | None                                                                            |
| Progression                  | Gradual (over 8-10 years)      | Gradual or stepwise with further ischemia | Gradual, but faster than Alzheimer’s disease | Gradual, but faster than Alzheimer’s disease                                    |
| Imaging                      | Possible global atrophy        | Cortical or subcortical on MRI            | Possible global atrophy                      | Atrophy in frontal & temporal lobes                                             |

Evaluation

-   MINI-COG: Screening test for cognitive impairment (highly sensitive)
    -   Ask pt to remember three words (banana, sunrise, chair). Ask pt
        to repeat immediately
    -   Ask pt to draw clock. After numbers are on the face, ask pt to
        draw hands to read 10 minutes after 11:00
        -   Correct is all numbers in right position AND hands pointing
            to the 11 and the 2
    -   Ask pt to recall the three words

<img src="/sites/default/files/inline-images/minicog.png" data-entity-type="file" data-entity-uuid="eb496c53-6380-4d92-b242-1121854a0ae0" alt="MINI COG" />

-   MOCA: Montreal Cognitive Assessment
    -   Lengthier test of cognition (highly specific for cognitive
        impairment)
    -   Useful for detecting subtle deficits as in Mild Cognitive
        Impairment (MCI)
    -   Scores:
        -   18-25: Mild cognitive impairment
        -   10-17: Moderate cognitive impairment
        -   \<10: Severe cognitive impairment

<!-- -->

-   Rule out reversible causes of dementia-like symptoms: **DEMENTIA**
    -   **​​​​​​​**
        D
        rugs
    -   E
        motional (depression)
    -   M
        etabolic (CHF, COPD, CKD, OSA)
    -   E
        ndocrine (Hypothyroidism, Hyperparathyroidism, Hyponatremia)
    -   N
        utrition (B12 deficiency)
    -   T
        rauma (chronic SDH)
    -   I
        nfection
    -   A
        rterial (vascular)
-   B12, thyroid studies
-   RPR, HIV testing in at-risk patient groups
    -   Neuropsych testing can be done for more clear patterns of
        dysfunction
        ​​​​​​​
-   MRI brain with contrast if concerned for inflammatory or infectious
    causes
    -   CJD: cortical ribboning on DWI with T2 hyperintensity in the
        thalamus and basal ganglia
    -   Sulcal crowding and bowing of the corpus callosum can be seen in
        NPH on imaging
-   ADMARK testing looks at tau and amyloid levels, also of limited help

Management

-   Targeting Cognitive Impairment
    -   Cholinesterase Inhibitors: Donepezil, rivastigmine
    -   NMDA antagonists: Memantine
        -   Indicated in moderate to severe AD in combination with
            cholinesterase inhibitors
        -   Fewer SE than cholinergic medications
    -   Vitamin supplementation (i.e. Vitamin E)
        -   Unclear benefit in delaying progression of dementia
-   Targeting Behaviors
    -   Depression: Treat with antidepressants (SSRI’s)
    -   Sleep Disturbance: Mirtazapine (7.5 mg nightly) or Trazodone (25
        mg nightly)
    -   Agitation: Try SSRI (citalopram, sertraline)
        -   Consider antipsychotics (black box warning increased risk of
            death in elderly)
